Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open study of MOVIPREP Orange (NRL0706) for routine colon cleansing prior to screening colonoscopies
2009-014845-95Phase 2Completed
- Sponsor
- Norgine
- Start
- Nov 2009
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of macrogol in colorectal cancer (CRC), sponsored by Norgine. Primary endpoints: Overall tolerance of NRL0706 intake (VAS), Overall acceptance of NRL0706 gut preparation (VAS) and 2 more. Started Nov 2009; status: completed.
02
Drugs
macrogol
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-014845-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014845-95.